Elevated plasma concentrations of lipoprotein (a)(Lp (a)) are a causal risk factor for the
development of atherothrombotic disorders including coronary heart disease. However, the …

Oxidized phospholipids (OxPL) are key mediators of the pro-atherosclerotic effects of
oxidized lipoproteins. They are particularly important for the pathogenicity of lipoprotein …

Background Mechanistic studies have established a biological role of sterol metabolism in
infection and immunity with clinical data linking deranged cholesterol metabolism during …

Abstract Lipoprotein (a)[Lp (a)], a distinct lipoprotein class, has become a major focus for
cardiovascular research. This review is written in light of the recent guideline and consensus …

An elevated level of lipoprotein (a)[Lp (a)] is a genetically regulated, independent, causal
risk factor for cardiovascular disease. However, the extensive variability in Lp (a) levels …

The role of lipoprotein (a)(Lp [a]) as a significant and possibly causal cardiovascular disease
(CVD) risk factor has been well established. Many studies, mostly experimental, have …

Atherosclerosis, as the official journal of the European Atherosclerosis Society (EAS),
decided that it would be timely to publish a comprehensive collection of review articles on …

Aspirin has long been recognized as a beneficial treatment for atherosclerotic
cardiovascular disease (ASCVD) due to its antiplatelet effects. However, there is a need to …

Background and aims Lipoprotein (a)[Lp (a)] and interleuking-6 (IL-6), an inflammation
biomarker, have been established as distinct targets of the residual atherosclerotic …

Objective The role of lipoprotein (a)(Lp [a]) as a possibly causal risk factor for atherosclerotic
cardiovascular disease has been well established. However, the clinical evidence regarding …